PARATEK PHARMACEUTICALS INC - FORM S-1/A - EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS, LLP - October 12, 2012

Attached files

file filename
S-1/A - FORM S-1/A AMENDMENT NO. 1 - PARATEK PHARMACEUTICALS INCd386058ds1a.htm
EX-4.4 - THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT - PARATEK PHARMACEUTICALS INCd386058dex44.htm
EX-3.2 - FORM OF RESTATED CERTIFICATE OF INCORPORATION - PARATEK PHARMACEUTICALS INCd386058dex32.htm
EX-3.4 - FORM OF RESTATED BY-LAWS OF THE REGISTRANT - PARATEK PHARMACEUTICALS INCd386058dex34.htm
EX-3.1.2 - CERTIFICATE OF AMENDMENT TO THE THIRD AMENDED AND RESTATED CERTIFICATE OF INCORP - PARATEK PHARMACEUTICALS INCd386058dex312.htm
EX-23.3 - CONSENT OF LOUISE MAWHINNEY AS A DIRECTOR NOMINEE - PARATEK PHARMACEUTICALS INCd386058dex233.htm
EX-10.3.1 - 2012 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN - PARATEK PHARMACEUTICALS INCd386058dex1031.htm
EX-10.23 - 2012 EMPLOYEE STOCK PURCHASE PLAN - PARATEK PHARMACEUTICALS INCd386058dex1023.htm
EX-10.24 - FORM OF INDEMNIFICATION AGREEMENT FOR OFFICERS AND DIRECTORS - PARATEK PHARMACEUTICALS INCd386058dex1024.htm
EX-10.3.2 - FORM OF STOCK OPTION AGREEMENT - PARATEK PHARMACEUTICALS INCd386058dex1032.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-1 of Paratek Pharmaceuticals, Inc. of our report dated August 10, 2012 relating to the financial statements of Paratek Pharmaceuticals, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

October 12, 2012